The global gastroesophageal reflux disease (GERD) device market is set to experience notable growth in the coming decade, with a projected market size of USD 1,207.3 million in 2024. According to recent market insights, the demand for GERD devices is expected to grow at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2034, reaching an estimated valuation of USD 1,719.5 million by 2034.
The increasing prevalence of GERD worldwide, coupled with the growing adoption of minimally invasive treatment options, is driving the demand for GERD devices. These devices offer a promising alternative to traditional medication and surgery, providing patients with more effective, long-term relief from the condition.
Technological advancements, such as improved durability and enhanced efficacy in device design, are further propelling the market. As the global population ages, with a significant portion suffering from GERD, the demand for these devices is expected to rise accordingly.
However, the market faces challenges, including stringent regulatory approval processes and restrictive reimbursement policies. Despite these hurdles, leading manufacturers in the GERD device market are actively pursuing strategic alliances and product innovations to overcome these constraints and support further market expansion.
The global GERD device market is poised for steady growth, offering significant opportunities for both established players and emerging companies in the healthcare industry.
Regional Outlook:
- The rise in the incidence of GERD in Asia Pacific stimulates demand for GERD devices, with lifestyle changes and food habits contributing to the increase.
- In Europe, digital health technology in GERD care is gaining traction, allowing for remote monitoring and increasing patient engagement in their treatment path.
- High healthcare spending and a well-established healthcare system in North America promote rapid developments in GERD device technology, emphasizing improving patient outcomes.
“Due to the increasing global prevalence of GERD, the gastroesophageal reflux disease (GERD) device market is expected to rise. Market expansion of GERD device is anticipated to be propelled by advancements in minimally invasive technologies and increasing demand for non-pharmacological treatment choices.”– opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Enhanced Market Demand: Discover Thorough Trends and Insights in Our Complete Report!
Key Takeaways:
- In the product category, the esophagoscopes and gastroscopes segment to acquire a market share of 90% in 2024.
- The diagnostic procedures segment in the procedure category to grab a share of 68% in 2024.
- From 2024 to 2034, the India gastroesophageal reflux disease (GERD) device industry is projected to strengthen at a 5.2% CAGR.
- Thailand gastroesophageal reflux disease (GERD) device sales are expected to surge at a CAGR of 5.0% through 2034.
- Through 2034, the Indonesia GERD device market is expected to expand at a CAGR of 3.4%.
- Between 2024 and 2034, the Malaysia gastroesophageal reflux disease (GERD) device industry is projected to evolve at a CAGR of 4.6%.
- Through 2034, the United States gastroesophageal reflux disease (GERD) device market is expected to expand at a CAGR of 2.6%.
- Sales of gastroesophageal reflux disease (GERD) device in Canada are forecast to rise at a CAGR of 2.9% until 2034.
- The Spain GERD device market is expected to evolve at a CAGR of 2.9% between 2024 and 2034.
- The France gastroesophageal reflux disease (GERD) device market anticipates flourishing at a CAGR of 2.3% between 2024 and 2034.
- The Germany GERD device market is projected to exhibit growth between 2024 and 2034 at a CAGR of 1.9%.
- Sales of gastroesophageal reflux disease (GERD) device in Italy are expected to rise at a CAGR of 2.0% until 2034.
- The United Kingdom gastroesophageal reflux disease (GERD) device industry is expected to experience expansion at a CAGR of 1.6% through 2034.
Competitive Landscape:
Prominent gastroesophageal reflux disease (GERD) device providers continue strategically concentrating on joint ventures and the distribution expansion of diverse products. To improve the treatment of diseases, leading gastroesophageal reflux disease (GERD) device vendors for the condition focus on technological innovation.
Latest Developments:
- China approved Peptest, a non-invasive radiofrequency device developed by RD Biomed to diagnose reflux devices. The gadget aids in the general management of reflux-related gadgets and finds pepsin in saliva samples.
- The EsophyX Z gastroesophageal reflux disease device, used to conduct transoral incisionless fundoplication, is an upgraded and newer model of the EsophyX device.
Prominent Gastroesophageal Reflux Disease (GERD) Device Vendors:
- Olympus Corporation
- Pentax Medical
- KARL STORZ SE and Co KG.
- Medtronic Plc
- Fujifilm Holdings Corporation
- EndoGastric Solutions
- Medigus Ltd.
- Diversatek Inc.
Key Segments:
By Product:
- Diagnostic Devices
- Manometry Systems
- PH Monitoring Systems
- Esophagoscopes and Gastroscopes
- Treatment Devices
- Ultrasonic Surgical Endostaplers
- Fundoplication Devices
- Sphincter Augmentation Devices
- Radiofrequency Ablation Devices
By Procedure:
- Diagnostic Procedures
- Fundoplication Procedures
- Radiofrequency Thermal Ablation
- Magnetic Sphincter Augmentation
By End User:
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The global gastroesophageal reflux disease therapeutics market size, which was estimated at USD 4.7 Billion in 2022 and it is predicted to have a revenue reduction to USD 3.4 Billion by 2032, declining at a CAGR of 3%. The decline of this gastroesophageal reflux disease therapeutics market is mostly due to the patent expiration of popular medications used to treat diseases of acid reflux.
The global medical device technology market strategies is experiencing steady growth, with a projected market size of USD 549.2 billion in 2024. This positive trend is expected to continue, with the industry reaching an estimated USD 877.7 billion by 2034. This translates to a CAGR of 4.8% over the next decade.
According to updated research, the global pharmaceutical excipient market share is set to hold a valuation of USD 972.9 million in 2024. Thereafter, the market’s progress over the coming decade is suggested to be solid, with a CAGR of 5.1%. As such, the market’s value by 2034 is marked to jump to USD 1,600.0 million.
The global anti-neoplastic pharmaceutical agents market growth is valued at USD 10,126.71 million as of 2022. The market is expected to grow at a CAGR of 11% during 2022-2032, and by 2032, it is expected to reach a valuation of USD 28,754 million.
The global advanced therapeutics pharmaceutical outsourcing market trends is expected to surge at a CAGR of 4.4% in the assessment period 2024 to 2034. The market value is projected to increase from USD 7,592.8 million in 2024 to USD 11,698.1 million by 2034.
In 2023, worldwide sales of specialty active pharmaceutical ingredients market are around USD 206.44 billion. The demand for specialty active pharmaceutical ingredients is expected to increase at a CAGR of 3.2% over the forecast period. The specialty active pharmaceutical ingredient (API) market value is expected to reach USD 282.88 billion by 2033.
According to Future Market Insights (FMI), the global oxytocic pharmaceuticals market opportunity is likely to generate USD 114.58 million in revenue in 2023. The oxytocic pharmaceuticals industry is anticipated to thrive at a 7.8% CAGR from 2023 to 2033, reaching USD 242.83 million by 2033.
The global oral solid dosage pharmaceutical formulation market outlook is projected to achieve USD 8,95,636.0 million by 2034, up from its estimated USD 6,29,582.6 million in 2024.
The global pharmaceutical filtration market forecast is expected to exhibit significant growth in the upcoming decade, from 2023 to 2033, with a CAGR of 8.9%. The global pharmaceutical filtration market is anticipated to reach USD 45.08 billion by 2033. As of 2023, the current market valuation is USD 19.19 billion.
The global dental service market development is predicted to be valued at USD 381.62 billion in 2024 and are expected to create a momentum of 6.2% CAGR over the next ten years and lead the market to USD 696.43 billion by 2034.
The pharmaceutical sterility testing market demand is anticipated to be generated global sales revenue of USD 1,250.7 million in 2023. Demand is expected to develop at a CAGR of 11.8% to reach a valuation of USD 3,815.6 million by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube